Inaktiver Wert

VERA PHARADR Aktie Nasdaq

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA	05.06.17
Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference	23.05.17
Verona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option	18.05.17
Grant of Options and RSUs and PDMR Dealings	03.05.17
Verona Pharma Announces Closing of Global Offering	02.05.17

Sektor